M
Marco Salvetti
Researcher at Sapienza University of Rome
Publications - 294
Citations - 13327
Marco Salvetti is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 44, co-authored 263 publications receiving 10931 citations. Previous affiliations of Marco Salvetti include Max Planck Society & Istituto Neurologico Mediterraneo.
Papers
More filters
Journal ArticleDOI
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register
Pietro Iaffaldano,Giuseppe Lucisano,Tommaso Guerra,Francesco Patti,Marco Onofrj,Vincenzo Brescia Morra,Mauro Zaffaroni,Carlo Pozzilli,Eleonora Cocco,Patrizia Sola,Giuseppe Salemi,Matilde Inglese,Roberto Bergamaschi,Claudio Gasperini,Antonella Conte,Marco Salvetti,Giacomo Lus,Giorgia Teresa Maniscalco,Rocco Totaro,Marika Vianello,Franco Granella,Elisabetta Ferraro,Umberto Aguglia,Maurizia Gatto,Francesca Sangalli,Clara Grazia Chisari,A. De Luca,Antonio Carotenuto,Damiano Baroncini,Delia Colombo,M Nica,Damiano Paolicelli,Giancarlo Comi,Massimo Filippi,Maria Pia Amato,Maria Trojano +35 more
TL;DR: Data-driven definitions demonstrated greater ability to capture SP transition than neurologist's definition and the global accuracy of DDA seems to be higher than the EXPAND definition.
Journal ArticleDOI
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Dimethylfumarate.
Maria Chiara Buscarinu,Francesca Gargano,Luana Lionetto,Matilde Capi,Emanuele Morena,Arianna Fornasiero,Roberta Reniè,Anna Chiara Landi,Giulia Pellicciari,Carmela Romano,Rosella Mechelli,Silvia Romano,Giovanna Borsellino,Luca Battistini,Maurizio Simmaco,Corrado Fagnani,Marco Salvetti,Giovanni Ristori +17 more
TL;DR: In this article, the effects of DMF on intestinal barrier permeability and mucosal immune responses were evaluated, together with clinical/MRI parameters, at three time-points: baseline (before therapy), after one (T1) and 9 months (T2) of treatment.
Journal ArticleDOI
The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment
Michela Sforza,Edoardo Bianchini,Diletta Alivernini,Marco Salvetti,Francesco E. Pontieri,G. Sette +5 more
TL;DR: In this paper , the authors reviewed current knowledge on cerebral vasoreactivity (CVR) alterations in the context of acute and chronic CVD and cognitive dysfunction, and the severity of these alterations seems to correlate with CVR derailment.
Book ChapterDOI
Effects of the Bacillus Calmette-Guérin (BCG) Vaccine in the Demyelinating Disease of the Central Nervous System
Giovanni Ristori,Silvia Romano,Stefania Cannoni,Carla Buttinelli,Giulia Coarelli,Nicola Vanacore,Carlo Pozzilli,Marco Salvetti +7 more
TL;DR: The bacillus Calmette-Guerin (BCG) vaccine was safe and effective in reducing disease activity as measured using magnetic resonance imaging (MRI), and in reducing the risk of developing persistent T1-hypointense lesions in patients with MS.
Journal ArticleDOI
Intestinal permeability in multiple sclerosis
Viviana Annibali,Claudia Policano,Maria Chiara Buscarinu,Luana Lionetto,Rosella Mechelli,Matilde Capi,Carlo Mattei,Eleonora Piras,Daniela F. Angelini,Ivan Monteleone,Giovanni Monteleone,Luca Battistini,Maurizio Simmaco,Giovanni Ristori,Marco Salvetti +14 more
TL;DR: A higher number of Tregs were found in AChR-MG, but a severe functional defect in their regulatory activity was found together with a decreased expression of the FOXP3, PD-L1 and GITR which are essential for T cell regulatory function.